Literature DB >> 17134697

Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop.

Serene R Lai1, Amanda P Cunningham, Vu Q Huynh, Lucy G Andrews, Trygve O Tollefsbol.   

Abstract

The human telomerase reverse transcriptase (hTERT) is the catalytic subunit of the enzyme telomerase which is responsible for telomeric maintenance and extension. Using RNA interference to knock down hTERT mRNA expression, we provide evidence that hTERT exerts extra-telomeric effects on the cell cycle and on its own regulatory proteins, specifically: p53 and p21. We tested our hypothesis that hTERT regulates its own expression through effects on upstream regulatory genes using transformed human embryonic kidney (HEK 293) cells, p53 and p16(INK4a) null human ovarian cancer SKOV-3 cells, and p53-null MDA-MB-157 human mammary cancer cells. In HEK 293 cells, hTERT knockdown resulted in elevated p53 and p21 transcription and a decrease in cellular proliferation. Similar results were observed in the MDA-MB-157 cell line where p21 was upregulated, correlating with cell growth inhibition. In contrast, we observed a decrease in expression of p21 in SKOV-3 cells with hTERT knockdown and cell growth appeared to be unaffected. These findings suggest that hTERT may be involved in a feedback loop system, thereby playing a role in its own regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17134697      PMCID: PMC1829489          DOI: 10.1016/j.yexcr.2006.10.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  44 in total

1.  Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells.

Authors:  S Yang; S Tutton; E Pierce; K Yoon
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 2.  Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT).

Authors:  J C Poole; L G Andrews; T O Tollefsbol
Journal:  Gene       Date:  2001-05-16       Impact factor: 3.688

3.  Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity.

Authors:  K Harada; K Kurisu; T Sadatomo; H Tahara; E Tahara; T Ide; E Tahara
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

4.  Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.

Authors:  T Kanaya; S Kyo; K Hamada; M Takakura; Y Kitagawa; H Harada; M Inoue
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

5.  Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.

Authors:  Patrícia de Souza Nascimento; Gilda Alves; Wolfgang Fiedler
Journal:  Oncol Rep       Date:  2006-08       Impact factor: 3.906

6.  Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.

Authors:  P T Ramirez; D M Gershenson; G Tortolero-Luna; L M Ramondetta; D Fightmaster; J T Wharton; J K Wolf
Journal:  Gynecol Oncol       Date:  2001-12       Impact factor: 5.482

7.  DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal.

Authors:  J I Young; J R Smith
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

8.  [Suppression of telomerase activity by plasmid-mediated RNA interference].

Authors:  Yan Li; Mingyuan Li; Ying Peng; Zhonghua Jiang; Wanyi Li; Hong Li
Journal:  Sheng Wu Yi Xue Gong Cheng Xue Za Zhi       Date:  2006-06

Review 9.  p21(WAF1/Cip1): more than a break to the cell cycle?

Authors:  G P Dotto
Journal:  Biochim Biophys Acta       Date:  2000-07-31

10.  Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.

Authors:  G Koutsodontis; I Tentes; P Papakosta; A Moustakas; D Kardassis
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

View more
  8 in total

Review 1.  Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.

Authors:  Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Journal:  Eur Heart J       Date:  2010-12-10       Impact factor: 29.983

Review 2.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

3.  Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2016-03-23       Impact factor: 3.905

4.  STAT1 mediates cellular senescence induced by angiotensin II and H₂O₂ in human glomerular mesangial cells.

Authors:  Sumin Jiao; Fanji Meng; Jin Zhang; Xue Yang; Xiaoyu Zheng; Lining Wang
Journal:  Mol Cell Biochem       Date:  2011-12-23       Impact factor: 3.396

5.  Multiple genetic variants in telomere pathway genes and breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Hui-Chen Wu; Mary Beth Terry; Qiao Wang; Patrick T Bradshaw; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

6.  Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.

Authors:  Huaping Chen; Charles N Landen; Yuanyuan Li; Ronald D Alvarez; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2013-01-16       Impact factor: 3.905

7.  The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  Clin Epigenetics       Date:  2011-01-26       Impact factor: 6.551

8.  RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth.

Authors:  Yu Qin; Wangbing Chen; Yao Xiao; Wendan Yu; Xin Cai; Meng Dai; Tingting Xu; Wenlin Huang; Wei Guo; Wuguo Deng; Taihua Wu
Journal:  Oncotarget       Date:  2015-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.